Clicky

ChemomAb Therapeutics Ltd.(CMMB)

Description: ChemomAb Ltd. develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases. The company is based in Tel Aviv, Israel.


Keywords: Medicine Clinical Medicine Immunology Antibodies Monoclonal Antibody Autoimmunity Autoimmune And Inflammatory Disease

Home Page: www.chemomab.com

CMMB Technical Analysis

Building 7
Tel Aviv, 6158002
Israel
Phone: 972 77 331 0156


Officers

Name Title
Dr. Dale R. Pfost Ph.D. Chairman & CEO
Dr. Adi Mor George Ph.D. Co-Founder, Chief Scientific Officer & Exec. Director
Mr. Donald R. Marvin MBA CFO, Exec. VP & COO
Barbara Lindheim Consulting VP of Investor & PR, Strategic Communications
Mr. Mitchell Lawrence Jones M.D., Ph.D. VP of Corp. Devel. & Strategy
Dr. Matthew Frankel M.B.A., M.D. Chief Medical Officer & VP of Drug Devel.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 13.0039
Trailing PE: 0
Price-to-Book MRQ: 0.6199
Price-to-Sales TTM: 0
IPO Date: 2019-02-12
Fiscal Year End: December
Full Time Employees: 20
Back to stocks